MAFA
MED icon

MJT & Associates Financial Advisory’s Medifast MED Stock Holding History

MJT & Associates Financial Advisory’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Hold
100
– – ﹤0.01% 418
2026
Q1 		$1.02K Hold
100
– – ﹤0.01% 405
2025
Q4 		$1.07K Hold
100
– – ﹤0.01% 411
2025
Q3 		$1.37K Hold
100
– – ﹤0.01% 415
2025
Q2 		$1.41K Buy
+100
New +$1.31K ﹤0.01% 417

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MJT & Associates Financial Advisory's MED Position: Q2 2026 in Review

MJT & Associates Financial Advisory held its Medifast (MED) position steady in Q2 2026 at 100 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

MJT & Associates Financial Advisory first reported a position in MED in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.41K in Q2 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • MJT & Associates Financial Advisory held 100 shares of Medifast worth $1.06K as of Q2 2026.
  • MJT & Associates Financial Advisory left its Medifast share count unchanged in Q2 2026.
  • Medifast made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #418 holding.
  • MJT & Associates Financial Advisory first reported a position in Medifast in Q2 2025 and has held it in 5 quarters since.
  • MJT & Associates Financial Advisory's Medifast position peaked at $1.41K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.